Skip to main content
SpringerLink
Log in

Early mesothelioma revisited

  • Introduction to Review Articles
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Aberle DR, Adams AM, Berg CD et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365(5):395–409. doi:10.1056/NEJMoa1102873

    Article  PubMed  Google Scholar 

  2. Infante M, Cavuto S, Lutman FR et al (2009) A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 180(5):445–453. doi:10.1164/rccm.200901-0076OC

    Article  PubMed  Google Scholar 

  3. Dutt N, Hari DT (2011) CT screening for lung cancer: so near, yet so far. Thorax. doi:10.1136/thoraxjnl-2011-200762

  4. Oken MM, Hocking WG, Kvale PA et al (2011) Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 306(17):1865–1873. doi:10.1001/jama.2011.1591

    Article  CAS  PubMed  Google Scholar 

  5. Sawabata N, Miyaoka E, Asamura H et al (2011) Japanese Lung Cancer Registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade. J Thorac Oncol 6(7):1229–1235. doi:10.1097/JTO.0b013e318219aae2

    Google Scholar 

  6. Robinson BW, Lake RA (2005) Advances in malignant mesothelioma. N Engl J Med 353(15):1591–1603. doi:10.1056/NEJMra050152

    Article  CAS  PubMed  Google Scholar 

  7. Tsao AS, Wistuba I, Roth JA et al (2009) Malignant pleural mesothelioma. J Clin Oncol 27(12):2081–2090. doi:10.1200/JCO.2008.19.8523

    Article  CAS  PubMed  Google Scholar 

  8. Milano MT, Zhang H (2010) Malignant pleural mesothelioma: a population-based study of survival. J Thorac Oncol 5(11):1841–1848. doi:10.1097/JTO.0b013e3181f1cf2b

    Article  PubMed  Google Scholar 

  9. Sugarbaker DJ, Flores RM, Jaklitsch MT et al (1999) Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117(1):54–63 (discussion 63–65)

    Google Scholar 

  10. Weder W, Kestenholz P, Taverna C et al (2004) Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. J Clin Oncol 22(17):3451–3457. doi:10.1200/JCO.2004.10.071

    Article  CAS  PubMed  Google Scholar 

  11. Scagliotti GV, Shin DM, Kindler HL et al (2003) Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma. J Clin Oncol 21(8):1556–1561. doi:10.1200/JCO.2003.06.122

    Article  CAS  PubMed  Google Scholar 

  12. Vogelzang NJ, Rusthoven JJ, Symanowski J et al (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21(14):2636–2644. doi:10.1200/JCO.2003.11.136

    Article  CAS  PubMed  Google Scholar 

  13. Rusch VW (2003) Pemetrexed and cisplatin for malignant pleural mesothelioma: a new standard of care? J Clin Oncol 21(14):2629–2630. doi:10.1200/JCO.2003.02.043

    Article  CAS  PubMed  Google Scholar 

  14. Sugarbaker DJ, Jaklitsch MT, Bueno R et al (2004) Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 128(1):138–146. doi:10.1016/j.jtcvs.2004.02.021

    Article  PubMed  Google Scholar 

  15. de Perrot M, McRae K, Anraku M et al (2008) Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma. Ann Thorac Surg 85(4):1206–1210. doi:10.1016/j.athoracsur.2007.11.065

    Article  PubMed  Google Scholar 

  16. Nakas A, Trousse DS, Martin-Ucar AE et al (2008) Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy. Eur J Cardiothorac Surg 34(4):886–891. doi:10.1016/j.ejcts.2008.06.010

    Article  PubMed  Google Scholar 

  17. Bolukbas S, Manegold C, Eberlein M et al (2011) Survival after trimodality therapy for malignant pleural mesothelioma: radical pleurectomy, chemotherapy with cisplatin/pemetrexed and radiotherapy. Lung Cancer 71(1):75–81. doi:10.1016/j.lungcan.2009.08.019

    Article  PubMed  Google Scholar 

  18. Shahin Y, Wellham J, Jappie R et al (2011) How successful is lung-preserving radical surgery in the mesothelioma and radical surgery-trial environment? A case-controlled analysis. Eur J Cardiothorac Surg 39(3):360–363. doi:10.1016/j.ejcts.2010.06.006

    Article  PubMed  Google Scholar 

  19. Teh E, Fiorentino F, Tan C et al (2011) A systematic review of lung-sparing extirpative surgery for pleural mesothelioma. J R Soc Med 104(2):69–80. doi:10.1258/jrsm.2010.100345

    Article  PubMed  Google Scholar 

  20. Rusch VW, Rosenzweig K, Venkatraman E et al (2001) A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 122(4):788–795. doi:10.1067/mtc.2001.116560

    Article  CAS  PubMed  Google Scholar 

  21. de Perrot M, Uy K, Anraku M et al (2007) Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 133(1):111–116. doi:10.1016/j.jtcvs.2006.06.044

    Article  PubMed  Google Scholar 

  22. Ahamad A, Stevens CW, Smythe WR et al (2003) Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 55(3):768–775

    Article  PubMed  Google Scholar 

  23. Allen AM, Czerminska M, Janne PA et al (2006) Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 65(3):640–645. doi:10.1016/j.ijrobp.2006.03.012

    Article  PubMed  Google Scholar 

  24. Rice DC, Stevens CW, Correa AM et al (2007) Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 84 (5):1685–1692 (discussion 1692–1683). doi:10.1016/j.athoracsur.2007.04.076

    Google Scholar 

  25. Chi A, Liao Z, Nguyen NP et al (2011) Intensity-modulated radiotherapy after extrapleural pneumonectomy in the combined-modality treatment of malignant pleural mesothelioma. J Thorac Oncol 6(6):1132–1141. doi:10.1097/JTO.0b013e3182199819

    Article  PubMed  Google Scholar 

  26. Neragi-Miandoab S (2006) Multimodality approach in management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 29(1):14–19. doi:10.1016/j.ejcts.2005.10.008

    Article  PubMed  Google Scholar 

  27. Rea F, Marulli G, Bortolotti L et al (2007) Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): feasibility and results. Lung cancer 57(1):89–95. doi:10.1016/j.lungcan.2007.02.004

  28. Weder W, Stahel RA, Bernhard J et al (2007) Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 18(7):1196–1202. doi:10.1093/annonc/mdm093

    Article  CAS  PubMed  Google Scholar 

  29. Krug LM, Pass HI, Rusch VW et al (2009) Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 27(18):3007–3013. doi:10.1200/JCO.2008.20.3943

    Article  CAS  PubMed  Google Scholar 

  30. Van Schil PE, Baas P, Gaafar R et al (2010) Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial. Eur Respir J 36(6):1362–1369. doi:10.1183/09031936.00039510

    Article  PubMed  Google Scholar 

  31. de Perrot M, Feld R, Cho BC et al (2009) Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol 27(9):1413–1418. doi:10.1200/JCO.2008.17.5604

    Article  PubMed  Google Scholar 

  32. Yamanaka T, Tanaka F, Hasegawa S et al (2009) A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma. Jpn J Clin Oncol 39(3):186–188. doi:10.1093/jjco/hyn145

    Article  PubMed  Google Scholar 

  33. Trousse DS, Avaro JP, D’Journo XB et al (2009) Is malignant pleural mesothelioma a surgical disease? A review of 83 consecutive extra-pleural pneumonectomies. Eur J Cardiothorac Surg 36(4):759–763. doi:10.1016/j.ejcts.2009.04.044

    Article  PubMed  Google Scholar 

  34. Treasure T, Lang-Lazdunski L, Waller D et al (2011) Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 12(8):763–772. doi:10.1016/S1470-2045(11)70149-8

    Article  PubMed  Google Scholar 

  35. Scherpereel A, Astoul P, Baas P et al (2010) Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J 35(3):479–495. doi:10.1183/09031936.00063109

    Article  CAS  PubMed  Google Scholar 

  36. Boutin C, Rey F (1993) Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: diagnosis. Cancer 72(2):389–393

    Google Scholar 

  37. Boutin C, Rey F, Gouvernet J et al (1993) Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: prognosis and staging. Cancer 72(2):394–404

    Google Scholar 

  38. Flores RM, Pass HI, Seshan VE et al (2008) Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 135(3):620–626, 626.e1–626.e3. doi:10.1016/j.jtcvs.2007.10.054

    Google Scholar 

  39. O’Brien ME, Watkins D, Ryan C et al (2006) A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: the MED trial. Ann Oncol 17(2):270–275. doi:10.1093/annonc/mdj073

    Article  PubMed  Google Scholar 

  40. Pass HI, Carbone M (2009) Current status of screening for malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg 21(2):97–104. doi:10.1053/j.semtcvs.2009.06.007

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The author has no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Thoracic Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, 663-8501, Japan

    Seiki Hasegawa

Authors
  1. Seiki Hasegawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seiki Hasegawa.

About this article

Cite this article

Hasegawa, S. Early mesothelioma revisited. Int J Clin Oncol 17, 30–32 (2012). https://doi.org/10.1007/s10147-011-0365-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-011-0365-5

Keywords

Search

Navigation